Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
104 participants
OBSERVATIONAL
2008-08-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056
Identification of Key Blood Molecular Markers for Immunotherapy
NCT00507702
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
NCT00096590
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Standard of Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease
* Ability to understand and the willingness to sign a written informed consent document.
* Existing staging CT imaging study
Exclusion Criteria
* History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
* Known pregnancy or positive urine pregnancy test in pre-menopausal women
* On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)
* No CT imaging studies, or contraindications to undergoing CT imaging
* Existing or anticipated need for a tunneled central venous catheter
* Clinic visitation to Stanford Cancer center for secondary consultation purposes only
* Inability to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haruka Itakura
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GI0003
Identifier Type: OTHER
Identifier Source: secondary_id
8502
Identifier Type: OTHER
Identifier Source: secondary_id
GI0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.